BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30775989)

  • 1. Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease.
    Kasahara H; Ikeda M; Nagashima K; Fujita Y; Makioka K; Tsukagoshi S; Yamazaki T; Takai E; Sanada E; Kobayashi A; Kishi K; Suto T; Higuchi T; Tsushima Y; Ikeda Y
    J Alzheimers Dis; 2019; 68(2):797-808. PubMed ID: 30775989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
    Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
    Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [
    Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
    Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of
    Hashimoto T; Yokota C; Koshino K; Temma T; Yamazaki M; Iguchi S; Shimomura R; Uehara T; Funatsu N; Hino T; Minematsu K; Iida H; Toyoda K
    Ann Nucl Med; 2017 Apr; 31(3):227-234. PubMed ID: 28220365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
    Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
    J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
    Wakabayashi Y; Ishii K; Hosokawa C; Hyodo T; Kaida H; Yamada M; Yagyu Y; Tsurusaki M; Kozuka T; Sugimura K; Murakami T
    Kobe J Med Sci; 2017 Mar; 62(5):E136-E141. PubMed ID: 28289271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
    van Westen D; Lindqvist D; Blennow K; Minthon L; Nägga K; Stomrud E; Zetterberg H; Hansson O
    Sci Rep; 2016 Feb; 6():20709. PubMed ID: 26856756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between white matter lesions and cerebral Aβ burden.
    Yi HA; Won KS; Chang HW; Kim HW
    PLoS One; 2018; 13(9):e0204313. PubMed ID: 30248123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of spillover from white matter by partial volume effect on quantification of amyloid deposition with [
    Matsubara K; Ibaraki M; Shimada H; Ikoma Y; Suhara T; Kinoshita T; Ito H
    Neuroimage; 2016 Dec; 143():316-324. PubMed ID: 27639351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease.
    Gertje EC; van Westen D; Panizo C; Mattsson-Carlgren N; Hansson O
    Neurology; 2021 Jan; 96(2):e193-e202. PubMed ID: 33046608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography of 11C-Pittsburgh compound B uptake in Alzheimer's disease: a voxel-based investigation of cortical and white matter regions.
    Faria DP; Duran FL; Squarzoni P; Coutinho AM; Garcez AT; Santos PP; Brucki SM; de Oliveira MO; Trés ES; Forlenza OV; Nitrini R; Buchpiguel CA; Busatto Filho G
    Braz J Psychiatry; 2019; 41(2):101-111. PubMed ID: 30540022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
    J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between white matter lesions and the cerebral glucose metabolism in patients with cognitive impairment.
    No HJ; Yi HA; Won KS; Chang HW; Kim HW
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):160-166. PubMed ID: 31053556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of (11)C-PiB equivocal PET findings.
    Hosokawa C; Ishii K; Hyodo T; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Hosono M; Hanada K; Ueda M; Saigo K; Murakami T
    Ann Nucl Med; 2015 Feb; 29(2):164-9. PubMed ID: 25373846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.